SCHEMBL32671086

SCHEMBL32671086

CC1(C)OB(c2cc(N3CC(F)C3)cc3c2cnn3COCC[Si](C)(C)C)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32671213 0.81 — —
SCHEMBL30976712 0.78 UCHL1 (0.34) —
SCHEMBL25367886 0.76 DGAT1 (0.33) —
SCHEMBL29493753 0.76 DGAT1 (0.33) —
SCHEMBL25367557 0.74 DGAT1 (0.34) —
SCHEMBL29493773 0.74 DGAT1 (0.33) —
SCHEMBL25368395 0.74 DGAT1 (0.33) —
SCHEMBL24343810 0.73 UCHL1 (0.35) —
SCHEMBL19626235 0.73 UCHL1 (0.39) —
SCHEMBL31219977 0.72 UCHL1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078119-A1 DEGRADER COMPOUNDS AND USES THEREOF BRISTOL MYERS SQUIBB CO (US) 2026-03-19 — — US disclosed
EP-4688771-A1 NOVEL FAK DEGRADER COMPOUNDS AND USES THEREOF Bristol-Myers Squibb Company (US) 2026-02-11 — — EP disclosed
Send feedback